Ultragenyx Pharmaceutical Inc. (RARE) gained 6.55% or 3.72 to $60.53. It is close to 1.05 million shares traded, which is 203.14% compare to the average total volume 516061. The market cap of RARE is $3.06 billion. The year to date change is 42.72%. The 52 week price range is from $37.44 to $90.98. Price of RARE have changed 2.66% during last week. It have changed 11.07% over last month, 11.99% over last 3 months, -26.56% over last 6 months and 17.91% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RARE is 48.36. It is -20.11% below current price. The 200-day Moving Averages for RARE is 65.68. It is 8.51% above current price. The 52-week High is 90.98. It is 50.31% from the current price. The 52-week Low is 37.44. It is -38.15% from current price.
There are some statistics of RARE. It is has market cap $3.06 billion. The share outstanding is 50.58 million. The average volume is 516061. The revenue is 2.41M. The gross profit is 2.41M. The percent of top 15 Institution holding is 168.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RARE is -37.39%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RARE is -32.03%.